Average Co-Inventor Count = 5.92
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (76 from 3,198 patents)
2. Human Genome Sciences, Inc. (11 from 676 patents)
3. Genetech, Inc. (3 from 98 patents)
4. Five Prime Therapeutics, Inc. (2 from 69 patents)
5. Glaxosmithkline Intellectual Property (no.2) Limited (1 from 92 patents)
92 patents:
1. 11559583 - Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer
2. 9775881 - Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD
3. 8518389 - Methods of inhibiting proliferation or immunoglobulin production of B cells using human tumor necrosis factor receptor TR-17 polypeptides
4. 7777007 - PRO9907 antibodies
5. 7718770 - PRO1305-polypeptides
6. 7700736 - PRO350 antibodies
7. 7696319 - PRO1772 antibodies
8. 7563867 - PRO4356 polypeptides
9. 7550569 - Antibodies that specifically bind to GMAD
10. 7504480 - PRO10275 polypeptides
11. 7498027 - Methods of treatment using human tumor necrosis factor receptor TR17 antibodies
12. 7491797 - PRO6308 polypeptide
13. 7479545 - PRO6001 antibodies
14. 7470771 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
15. 7456261 - PRO9830 antibodies